Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...
CLEVELAND, Nov. 4, 2025 /PRNewswire/ -- Hyster-Yale, Inc. (NYSE: HY) reported the following consolidated results for the three months ended September 30, 2025. (1) Reconciliations of reported to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback